Compare, Analyse Novartis with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs TEVA PHARMA (Israel) - Comparison Results

NOVARTIS     Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 NOVARTIS   TEVA PHARMA
EQUITY SHARE DATA
    NOVARTIS
Mar-18
TEVA PHARMA
Dec-13
NOVARTIS/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs7582,973-   
Low Rs5792,582-   
Sales per share (Unadj.) Rs228.41,706.1-  
Earnings per share (Unadj.) Rs31.7106.6-  
Cash flow per share (Unadj.) Rs32.8244.5-  
Dividends per share (Unadj.) Rs10.0093.30-  
Dividend yield (eoy) %1.53.4 44.5%  
Book value per share (Unadj.) Rs297.11,895.1-  
Shares outstanding (eoy) m24.69848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.91.6 179.8%   
Avg P/E ratio x21.126.1 80.8%  
P/CF ratio (eoy) x20.411.4 179.6%  
Price / Book Value ratio x2.21.5 153.5%  
Dividend payout %31.587.5 36.0%   
Avg Mkt Cap Rs m16,5052,355,388 0.7%   
No. of employees `0000.744.9 1.5%   
Total wages/salary Rs m1,4450-   
Avg. sales/employee Rs Th8,441.332,189.6 26.2%   
Avg. wages/employee Rs Th2,163.60-   
Avg. net profit/employee Rs Th1,173.12,010.9 58.3%   
INCOME DATA
Net Sales Rs m5,6391,446,763 0.4%  
Other income Rs m1,7180-   
Total revenues Rs m7,3571,446,763 0.5%   
Gross profit Rs m-63396,197 -0.0%  
Depreciation Rs m25116,943 0.0%   
Interest Rs m5528,417 0.2%   
Profit before tax Rs m1,575250,837 0.6%   
Minority Interest Rs m01,140 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-164,661 0.0%   
Tax Rs m792-3,062 -25.8%   
Profit after tax Rs m78490,378 0.9%  
Gross profit margin %-1.127.4 -4.0%  
Effective tax rate %50.3-1.2 -4,116.1%   
Net profit margin %13.96.2 222.5%  
BALANCE SHEET DATA
Current assets Rs m9,522977,138 1.0%   
Current liabilities Rs m3,296852,147 0.4%   
Net working cap to sales %110.48.6 1,277.9%  
Current ratio x2.91.1 251.9%  
Inventory Days Days3791 40.3%  
Debtors Days Days2896 29.6%  
Net fixed assets Rs m46472,545 0.0%   
Share capital Rs m1233,561 3.5%   
"Free" reserves Rs m7,2130-   
Net worth Rs m7,3361,607,079 0.5%   
Long term debt Rs m0739,762 0.0%   
Total assets Rs m11,1053,306,317 0.3%  
Interest coverage x29.59.8 300.0%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.50.4 116.0%   
Return on assets %7.63.6 210.2%  
Return on equity %10.75.6 189.9%  
Return on capital %22.24.9 450.7%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-3,5700-   
CASH FLOW
From Operations Rs m1,610230,539 0.7%  
From Investments Rs m687-81,689 -0.8%  
From Financial Activity Rs m-2,677-276,547 1.0%  
Net Cashflow Rs m-380-127,697 0.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 71.22 Rs / USD

Compare NOVARTIS With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare NOVARTIS With: ALEMBIC PHARMA  UNICHEM LAB  PLETHICO PHARMA  AJANTA PHARMA  FRESENIUS KABI ONCO.  



Today's Market

Indian Stock Markets Remain in Green This Week: Is the Rebound Here?(Podcast)

After a long period of underperformance, stock markets traded in green territory throughout the week. So, is this is a trend reversal and is the bottom forming in the market?

Related Views On News

NOVARTIS Announces Quarterly Results (1QFY20); Net Profit Down 92.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NOVARTIS has posted a net profit of Rs 8 m (down 92.1% YoY). Sales on the other hand came in at Rs 1 bn (down 20.8% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (4QFY19); Net Profit Down 26.2% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, NOVARTIS has posted a net profit of Rs 195 m (down 26.2% YoY). Sales on the other hand came in at Rs 1 bn (down 11.9% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound? (The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Two Stocks to Buy in the Great Indian Festival (Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Oct 18, 2019 (Close)

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NOVARTIS - J.B.CHEMICALS COMPARISON

COMPARE NOVARTIS WITH

MARKET STATS